Literature reports suggest that the expression of steroid receptor and aromatase in LG-ESS indicates that adjuvant therapy with progesterone, GnRH analogues, or aromatase inhibitors could be effective (18, 19). Here, CYP19A1 is linked to endometrioid stromal sarcoma.